IIVAX
Price
$25.69
Change
+$0.26 (+1.02%)
Updated
Jun 6 closing price
Net Assets
623.92M
JVMCX
Price
$26.03
Change
+$0.25 (+0.97%)
Updated
Jun 6 closing price
Net Assets
21.45B
Interact to see
Advertisement

IIVAX vs JVMCX

Header iconIIVAX vs JVMCX Comparison
Open Charts IIVAX vs JVMCXBanner chart's image
Transamerica Small/Mid Cap Value A
Price$25.69
Change+$0.26 (+1.02%)
VolumeN/A
Net Assets623.92M
JHancock Disciplined Value Mid Cap C
Price$26.03
Change+$0.25 (+0.97%)
VolumeN/A
Net Assets21.45B
IIVAX vs JVMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IIVAX vs. JVMCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IIVAX is a StrongBuy and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.5B vs. IIVAX (624M). IIVAX pays higher dividends than JVMCX: IIVAX (0.81) vs JVMCX (0.00). IIVAX was incepted earlier than JVMCX: IIVAX (24 years) vs JVMCX (14 years). JVMCX (1.88) is less costly to investors than IIVAX (1.20). JVMCX (47.00) and IIVAX (46.00) have comparable annual turnover. IIVAX (1000) and JVMCX (1000) have matching initial minimum investment requirements. JVMCX annual gain was more profitable for investors over the last year : -4.66 vs. IIVAX (-7.97). JVMCX return over 5 years is better than : 33.39 vs. IIVAX (14.87).
IIVAXJVMCXIIVAX / JVMCX
Total Expense Ratio1.191.8764%
Annual Report Gross Expense Ratio1.201.8864%
Fund Existence24 years14 years-
Gain YTD-2.3051.897-121%
Front Load6%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets624M21.5B3%
Annual Yield % from dividends0.810.00-
Returns for 1 year-7.97-4.66171%
Returns for 3 years-14.191.47-964%
Returns for 5 years14.8733.3945%
Returns for 10 years-5.0025.96-19%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO31.580.57
+1.84%
ALPS Medical Breakthroughs ETF
FTXL87.420.37
+0.43%
First Trust Nasdaq Semiconductor ETF
VUSB49.61-0.01
-0.02%
Vanguard Ultra-Short Bond ETF
XPP24.45-0.05
-0.22%
ProShares Ultra FTSE China 50
PCRB48.16-0.25
-0.52%
Putnam ESG Core Bond ETF